建立并利用RNA干擾陣列式篩選模式研究PrP蛋白的功能
[Abstract]:Prion is an infectious pathogen causing fatal degenerative neuropathy in humans and animals by a unique mechanism that is not yet fully understood. It is thought that the transformation of membrane surface glycoprotein PrP~C, which is highly expressed in brain tissue, into PrP~ (Sc), encoded by Prnp gene, is the cause of prion disease. Some scholars believe that the function of PrP~C may be closely related to neuronal apoptosis in prion disease, but the function and mechanism of PrP~C are not clear.
In order to study the function of PrP protein, a series of transgenic and knockout mice models have been established, but the results are not satisfactory. It is found that PrP~C can interact with many proteins and nucleic acids in cells by yeast two-hybrid technique, but there is still no evidence of intracellular interaction and the interaction is caused by this interaction. Evidence of alterations in the biological function of PrP is therefore necessary to study the function of PrP by more effective techniques.
RNA interference (RNAi) is a sequence-specific post-transcriptional gene silencing induced by double-stranded RNA (dsRNA) molecules at the mRNA level, which can effectively and specifically inhibit target gene expression; moreover, the emerging high-throughput RNAi library technology has been successfully applied to functional genomics research, signal transduction pathway However, various forms of RNA library and screening methods have their advantages and disadvantages. Considering the advantages of RNAi library technology and the complexity of the research on the function of PrP, it is necessary to establish an economical and practical RNA library technology to study the function of PrP.
To this end, we set out to establish a PEI-mediated reverse transfection plasmid library array for small hairpin RNA (shRNA) expression, and applied it to the study of PrP regulating STS-induced apoptosis.
1. established RNAi array screening mode.
We constructed a shRNA expression plasmid set including 59 human apoptosis-related genes and 6 human PrP alternative sequences. A low-cost, efficient, non-viral, non-liposome cationic polyethylenimine (PEI) was selected as the transfection reagent for RNA arrays, and a PEI-mediated reverse transfection technique was established. The results showed that the transfection efficiency of PEI in HEK293 cells was similar to that of Lipofectamine 2000, and the transfection efficiency was about 55%. There was no significant difference between them (x~2=0.439, P>0.05), but the cost was very different. The efficiency of PEI mediated plasmid reverse transfection was higher than that of routine transfection (x~2=8.598, P<0.05). The reverse transfection process can be completed in one day, which is simpler than the conventional transfection process, so it can meet the needs of large-scale RNAi array screening.
In order to verify the efficiency of gene silencing in reverse transfection, semi-quantitative RT-PCR and Western blot were used to verify the specific inhibition of human PrP-targeted RNAi plasmid PR6 on PrP expression. Simulated array screening showed that PR6 plasmid could regulate STS-induced apoptosis in shRNA expression plasmids targeting PrP. Arrays can be used effectively for gene function screening.
2. several genes related to STS induced apoptosis were screened out.
In order to study the regulatory effect of PrP on STS-induced apoptosis, PEI-mediated reverse transfection shRNA expression plasmid array was used to screen 22 genes including PrP, Cyc, Bax, CDK6, CDK7 and E2F5, which were related to STS-induced apoptosis in HEK293 cells. Bax can inhibit the expression of Bax, suggesting that Bax is the target of PrP to regulate STS-induced apoptosis. It suggests that the RNA library array screening model can be effectively applied to the study of apoptosis-related gene function, including in mammalian cells. These screening results provide clues to further study the mechanism of PrP regulating STS-induced apoptosis.
3. it is confirmed that PrP plays a different role in regulating STS induced apoptosis in Neuron2A and HEK293 cells.
On the basis of the above screening results, in order to further confirm the mechanism of PrP regulating STS-induced apoptosis, we transfected PrP-RNAi plasmid and PrP expression plasmid into Neuron2A and HEK293 cells respectively, on the one hand to verify the screened PrP regulating STS-induced apoptosis through Bax, on the other hand, from cell morphology, apoptosis. The results showed that PrP participated in STS-induced apoptosis in Neuron 2A and HEK293 cells, but the effect was different. In Neuron 2A cells, PrP was inhibited by RNAi and promoted STS-induced apoptosis, while PrP overexpression was inhibited. In HEK293 cells, PrP inhibited STS-induced apoptosis and PrP overexpression promoted STS-induced apoptosis. Although PrP regulated STS-induced apoptosis differently in these two cells, the results showed that both were related to Bax, which further confirmed our screening results.
Based on the normal function of PrP and focusing on the disease-related apoptosis regulatory network, we established and applied RNAi library array screening model to study the regulatory function and mechanism of PrP on STS-induced apoptosis, which laid the foundation for further improving the high-throughput RNAi screening technology for gene function. The results of screening and the function of PrP were verified by experiments. The function and mechanism of PrP were studied by RNAi array screening, and the role of PrP in regulating STS-induced apoptosis in different cells by Bax was not reported.
【學(xué)位授予單位】:中國(guó)協(xié)和醫(yī)科大學(xué)
【學(xué)位級(jí)別】:博士
【學(xué)位授予年份】:2006
【分類號(hào)】:R346
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 王娜;韓雅玲;陶杰;閆承慧;;p38 MAPK介導(dǎo)E1A激活基因阻遏子蛋白調(diào)控人血管內(nèi)皮細(xì)胞凋亡[J];中國(guó)病理生理雜志;2011年07期
2 張琳;郝選明;鄧樹勛;肖鵬;;Nur77與胸腺細(xì)胞陰性選擇[J];南陽師范學(xué)院學(xué)報(bào);2011年06期
3 馮紅;劉衛(wèi);戰(zhàn)銳;王新興;錢令嘉;;NGFI-B在應(yīng)激損傷心肌細(xì)胞中的亞細(xì)胞定位及其生物學(xué)效應(yīng)[J];中國(guó)應(yīng)用生理學(xué)雜志;2011年03期
4 ;[J];;年期
5 ;[J];;年期
6 ;[J];;年期
7 ;[J];;年期
8 ;[J];;年期
9 ;[J];;年期
10 ;[J];;年期
相關(guān)會(huì)議論文 前10條
1 劉欣安;廖凱;田青;王建枝;;Tau蛋白去磷酸化促凋亡及其機(jī)制研究[A];2009全國(guó)抗衰老與老年癡呆學(xué)術(shù)會(huì)議論文匯編[C];2009年
2 李長(zhǎng)菲;劉秋燕;陳偉;李楠;王麗;王玉珍;曹雪濤;;一種新型凋亡蛋白EAPF促進(jìn)腫瘤壞死因子α誘導(dǎo)的內(nèi)質(zhì)網(wǎng)相關(guān)的細(xì)胞凋亡[A];中國(guó)免疫學(xué)會(huì)第五屆全國(guó)代表大會(huì)暨學(xué)術(shù)會(huì)議論文摘要[C];2006年
3 劉欣安;廖凱;田青;王建枝;;Tau蛋白去磷酸化促凋亡及其機(jī)制研究[A];湖北省暨武漢市病理生理學(xué)會(huì)第十四屆學(xué)術(shù)年會(huì)論文匯編[C];2008年
4 劉雨田;王志亮;;我國(guó)朊病毒及朊病毒病的研究現(xiàn)狀[A];人畜共患傳染病防治研究新成果匯編[C];2004年
5 尤學(xué)芬;陸德炎;謝玉娟;;全反式維甲酸與紫杉醇、阿霉素聯(lián)合誘導(dǎo)HL-60細(xì)胞凋亡的研究[A];第10屆全國(guó)實(shí)驗(yàn)血液學(xué)會(huì)議論文摘要匯編[C];2005年
6 叢秀麗;李彬;楊仁池;馮四洲;陳賽娟;韓忠朝;;Bcr3/abl2和VEGF基因反義寡核苷酸聯(lián)合應(yīng)用對(duì)K562細(xì)胞作用的體內(nèi)、外研究[A];第10屆全國(guó)實(shí)驗(yàn)血液學(xué)會(huì)議論文摘要匯編[C];2005年
7 韓之波;王晗;任賀;趙輝;劉擁軍;韓忠朝;;RNA干擾沉默HIF-1α對(duì)人乳腺癌細(xì)胞功能的影響[A];第四屆中國(guó)腫瘤學(xué)術(shù)大會(huì)暨第五屆海峽兩岸腫瘤學(xué)術(shù)會(huì)議論文集[C];2006年
8 謝幸;;惡性腫瘤的分子靶向治療及其在婦科腫瘤中的應(yīng)用[A];第四屆長(zhǎng)三角婦產(chǎn)科學(xué)術(shù)論壇暨浙江省2009年婦產(chǎn)科學(xué)術(shù)年會(huì)論文匯編[C];2009年
9 齊振華;譚柏林;張國(guó)平;;乳香提取物對(duì)HL60細(xì)胞活性調(diào)控作用[A];2000全國(guó)腫瘤學(xué)術(shù)大會(huì)論文集[C];2000年
10 鐘仰進(jìn);曾林;劉吉平;黃志君;梁紅;鄧小娟;楊婉瑩;曹陽;顧世紅;;家蠶蛹變態(tài)期絲腺組織自發(fā)的和誘導(dǎo)的細(xì)胞凋亡特征(昆蟲學(xué)報(bào)已受理)[A];中國(guó)蠶學(xué)會(huì)第四屆青年學(xué)術(shù)研討會(huì)會(huì)議論文集[C];2004年
相關(guān)博士學(xué)位論文 前10條
1 張瑩;建立并利用RNA干擾陣列式篩選模式研究PrP蛋白的功能[D];中國(guó)協(xié)和醫(yī)科大學(xué);2006年
2 王新興;TR3在應(yīng)激致心肌細(xì)胞凋亡線粒體機(jī)制中的作用及其分子基礎(chǔ)[D];中國(guó)人民解放軍軍事醫(yī)學(xué)科學(xué)院;2009年
3 王家棟;丙型肝炎病毒非結(jié)構(gòu)蛋白NS5A與細(xì)胞蛋白FKBP38相互作用及對(duì)細(xì)胞凋亡影響的研究[D];復(fù)旦大學(xué);2006年
4 劉安恒;氯離子通道阻斷劑對(duì)STS誘導(dǎo)的心肌細(xì)胞凋亡的影響及信號(hào)轉(zhuǎn)導(dǎo)[D];第四軍醫(yī)大學(xué);2008年
5 王_";肝細(xì)胞肝癌和肺癌中乙酰膽堿自泌系統(tǒng)的研究[D];復(fù)旦大學(xué);2007年
6 楊芬;倍半萜類化合物Hirsutanols A抗腫瘤作用及作用機(jī)制研究[D];廣州中醫(yī)藥大學(xué);2010年
7 趙懷龍;HAX-1與c-Abl非受體酪氨酸激酶相互作用及其生物學(xué)意義[D];中國(guó)人民解放軍軍事醫(yī)學(xué)科學(xué)院;2008年
8 叢秀麗;Bcr3/abl2和VEGF基因反義寡核苷酸聯(lián)合應(yīng)用對(duì)K562細(xì)胞作用的體內(nèi)、外研究[D];中國(guó)協(xié)和醫(yī)科大學(xué);2005年
9 王海紅;Tau蛋白磷酸化對(duì)抗細(xì)胞凋亡及其機(jī)制的研究[D];華中科技大學(xué);2007年
10 李兆才;苦馬豆素誘導(dǎo)A549細(xì)胞和Eca-109細(xì)胞凋亡的信號(hào)轉(zhuǎn)導(dǎo)通路研究[D];西北農(nóng)林科技大學(xué);2012年
相關(guān)碩士學(xué)位論文 前10條
1 魏美嬌;新型腫瘤細(xì)胞凋亡誘導(dǎo)劑篩選及作用機(jī)理研究[D];大連理工大學(xué);2006年
2 梅國(guó)勇;朊蛋白與信號(hào)蛋白14-3-3β相互作用的研究[D];安徽理工大學(xué);2009年
3 郭燕;微管相關(guān)蛋白2與朊蛋白相互作用的研究[D];西北農(nóng)林科技大學(xué);2006年
4 廖凱;Tau蛋白去磷酸化對(duì)細(xì)胞凋亡的影響及其機(jī)制的研究[D];華中科技大學(xué);2008年
5 李建業(yè);5-Fu誘導(dǎo)結(jié)腸癌細(xì)胞凋亡與NF-κB活化及uPA表達(dá)的關(guān)系[D];山西醫(yī)科大學(xué);2007年
6 邵明;硼替佐米對(duì)K562細(xì)胞增殖、凋亡及其對(duì)XIAP表達(dá)的影響[D];鄭州大學(xué);2010年
7 和樹同;鉀通道在鼻咽癌細(xì)胞容積調(diào)節(jié)和凋亡中的作用[D];暨南大學(xué);2010年
8 蘇翔;氯化鋰對(duì)肝臟缺血再灌注損傷的保護(hù)作用[D];南京醫(yī)科大學(xué);2010年
9 張燕;JWA通過線粒體凋亡通路影響腫瘤細(xì)胞耐藥性[D];南京醫(yī)科大學(xué);2009年
10 彭程飛;E1A基因阻遏子基因抑制TNF-α誘導(dǎo)的骨髓間充質(zhì)干細(xì)胞凋亡的作用與機(jī)制研究[D];第四軍醫(yī)大學(xué);2011年
,本文編號(hào):2220589
本文鏈接:http://sikaile.net/yixuelunwen/binglixuelunwen/2220589.html